Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments
Department of Psychiatry
Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; MEDLINE; Male; Middle Aged; Monoamine Oxidase Inhibitors; Placebo Effect; Recurrence; Research Design; Serotonin Uptake Inhibitors; Severity of Illness Index; United States
BACKGROUND: Many patients with unipolar depression experience a return of depressive symptoms while taking a constant maintenance dose of an antidepressant.
METHOD: All cited studies were found using computerized literature searches of the MEDLINE database since 1966.
RESULTS: The return of depressive symptoms during maintenance antidepressant treatment has occurred in 9% to 57% of patients in published trials. Possible explanations include loss of placebo effect, pharmacologic tolerance, increase in disease severity, change in disease pathogenesis, the accumulation of a detrimental metabolite, unrecognized rapid cycling, and prophylactic inefficacy.
CONCLUSION: Although several strategies have been proposed to overcome the loss of antidepressant efficacy, double-blind controlled studies are needed to ascertain the optimal strategy for this perplexing clinical problem.
J Clin Psychiatry. 1998 Jun;59(6):279-88.
The Journal of clinical psychiatry
Byrne SE, Rothschild AJ. (1998). Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. Psychiatry Publications and Presentations. Retrieved from https://escholarship.umassmed.edu/psych_pp/48